Venture Map · Round
Telum Therapeutics — Seed · €4.1M
Announced 2020-07-13 · Pamplona · Biotech
Telum Therapeutics raised €4.1M in its first round to develop enzybiotics, which are therapies based on bacteriophage lytic enzymes, against multidrug-resistant bacterial infections. The money will take its lead candidate IKB206 towards the clinic. Invivo Ventures led, and Clave Capital and CDTI-Innvierte co-invested.
RoundSeed
Amount€4.1M
LeadInvivo Ventures
Date2020-07-13
CityPamplona
SectorBiotech
